Cargando…
Boron Neutron Capture Therapy Combined with Early Successive Bevacizumab Treatments for Recurrent Malignant Gliomas – A Pilot Study
Recurrent malignant gliomas (RMGs) are difficult to control, and no standard protocol has been established for their treatment. At our institute, we have often treated RMGs by tumor-selective particle radiation called boron neutron capture therapy (BNCT). However, despite the cell-selectivity of BNC...
Autores principales: | SHIBA, Hiroyuki, TAKEUCHI, Koji, HIRAMATSU, Ryo, FURUSE, Motomasa, NONOGUCHI, Naosuke, KAWABATA, Shinji, KUROIWA, Toshihiko, KONDO, Natsuko, SAKURAI, Yoshinori, SUZUKI, Minoru, ONO, Koji, OUE, Shiro, ISHIKAWA, Eiichi, MICHIUE, Hiroyuki, MIYATAKE, Shin-Ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300692/ https://www.ncbi.nlm.nih.gov/pubmed/30464150 http://dx.doi.org/10.2176/nmc.oa.2018-0111 |
Ejemplares similares
-
ACT-3 Reactor-based boron neutron capture therapy with add-on bevacizumab for recurrent malignant glioma: The final report
por: Furuse, Motomasa, et al.
Publicado: (2021) -
Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
por: Miyatake, Shin-Ichi, et al.
Publicado: (2014) -
Boron Neutron Capture Therapy for Malignant Brain Tumors
por: MIYATAKE, Shin-Ichi, et al.
Publicado: (2016) -
Intratumoral and peritumoral post-irradiation changes, but not viable tumor tissue, may respond to bevacizumab in previously irradiated meningiomas
por: Furuse, Motomasa, et al.
Publicado: (2015) -
Identification of early and distinct glioblastoma response patterns treated by boron neutron capture therapy not predicted by standard radiographic assessment using functional diffusion map
por: Hiramatsu, Ryo, et al.
Publicado: (2013)